Age Verification Required
You must be 21 years of age or older to enter this site. All products are for research use only and not intended for human consumption.
By entering you confirm you are 21+ and agree to our Terms & Conditions and Research Disclaimer.
LY3298176 · Dual GIP/GLP-1 Receptor Agonist · Lyophilized Powder
Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Widely studied for its effects on insulin secretion dynamics, glucose metabolism, and metabolic regulatory networks.
For Research Use Only · Not for Human Consumption
Tirzepatide is a novel dual agonist at both the GIP and GLP-1 receptors, making it a unique research tool for studying the coordinated effects of incretin hormones on metabolic regulation. It is supplied as a lyophilized powder at ≥99% purity confirmed by HPLC. Each batch is independently tested and arrives with a full COA.
Tirzepatide has generated significant interest in metabolic research due to its dual mechanism of action. Unlike single GLP-1 agonists, its simultaneous engagement of GIP receptors provides researchers with a compound that can probe the synergistic effects of two major incretin pathways.
For laboratory research use only. Consult relevant literature before designing experimental protocols.
Certificate of Analysis
GIP/GLP-1 Dual Receptor Agonist
Amino Acid Sequence
Y-Aib-E-G-T-F-T-S-D-Y-S-I-Aib-L-D-K-I-A-Q-K(YE-AEEA-C20diacid)-A-F-V-Q-W-L-I-A-G-G-P-S-S-G-A-P-P-P-S-NH₂
39-mer GIP/GLP-1 dual agonist; C20 fatty diacid at K20 confirmed by LC-MS
| Test Parameter | Specification | Result |
|---|---|---|
| Appearance | Conforms to specification: White lyophilized powder | PASS — White lyophilized powder |
| Purity / Assay | ≥99.0% (HPLC) | PASS — 99.5% |
| Identity | Conforms to reference standard (MS / HPLC) | PASS — Confirmed |
| Solubility | Soluble in water | PASS — Clear solution |
